Uptake of the OMERACT-OARSI Hip and Knee Osteoarthritis Core Outcome Set: Review of Randomized Controlled Trials from 1997 to 2017
Research output: Contribution to journal › Journal article › Research › peer-review
OBJECTIVE: To assess the uptake of the OMERACT-OARSI (Outcome Measures in Rheumatology- Osteoarthritis Research Society International) core outcome set (COS) domains in hip and/or knee osteoarthritis (OA) trials.
METHODS: There were 382 trials of hip and/or knee OA identified from the ClinicalTrial.gov registry from 1997 to 2017. Frequency of COS adoption was assessed by year and per 5-yearly phases.
RESULTS: COS adoption decreased from 61% between 1997 and 2001 to 38% between 2012 and 2016. Pain (95%) and physical function (86%) were most consistently adopted. Patient's global assessment (48%) was the principal missing domain.
CONCLUSION: Limited adoption of the COS domains indicates that further consideration to improve uptake is required.
| Original language | English |
|---|---|
| Journal | Journal of Rheumatology |
| Volume | 46 |
| Issue number | 8 |
| Pages (from-to) | 976-980 |
| Number of pages | 5 |
| ISSN | 0315-162X |
| DOIs | |
| Publication status | Published - Aug 2019 |
- Adoption, Core outcome set, Domain, OMERACT, Trial registration
Research areas
ID: 57855722